Início › Obesidade › Tennessee

Ensaios clínicos de Obesidade em Tennessee

38 estudos para Obesidade estão buscando participantes em locais em Tennessee.

Cidades em Tennessee

Texto oficial do estudo (Inglês)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Holston Medical Group - Bristol /ID# 282045, Bristol
New Phase Research & Development /ID# 282131, Knoxville
Summit Medical Group- Halls Family Physicians /ID# 282435, Knoxville
e mais 1

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

M3 Wake Research Chattanooga, Chattanooga

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

LifeDoc Health, Memphis

RecrutandoFase 3

Idades de 8 a 18 · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07253285

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

AMR Clinical, Nashville

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07837973

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Gastroenterology Center Of The Midsouth, Cordova

RecrutandoFase 3

Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Vanderbilt Health One Hundred Oaks, Nashville

RecrutandoFase 3

Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastroenterology Center Of The Midsouth, Cordova

RecrutandoFase 3

Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Franklin
Research Site, Jackson
Research Site, Knoxville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Stern Cardiovascular Foundation Inc, Germantown
Accellacare of Knoxville, Knoxville
Cardiovascular Research of Knoxville North Knoxville Medical Center, Powell
e mais 1

RecrutandoFase 3

Idades de 45 a 99 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

AMR Clinical, Nashville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Quality Medical Research, Nashville

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07589608

Transition to Ambulatory Bariatric Surgery (TABS) Trial

Vanderbilt University Medical Center, Nashville

Recrutando

Idades de 25 a 55 · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT07011628

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Memphis

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Memphis

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Apex Research Foundation, LLC, Jackson
The Jackson Clinic PA, Jackson
Parkway Cardiology Associates, Oak Ridge
e mais 2

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Innovative Clinical Research, Clarksville
Clinical Research Associates, Nashville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Nashville

RecrutandoFase 3Voluntários saudáveis bem-vindos

Idades de 18 a 79 · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Quality Medical Research, Nashville

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

DelRicht Research - Thompson's Station, Smyrna

RecrutandoFase 4

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailea Clinical Site, Memphis

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

New Phase Research and Development, Knoxville

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Chattanooga

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284875

The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function

Vanderbilt University Medical Center, Nashville

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT05972564

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Kingsport

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Balad Hlth Sys-Welmont CardCVA, Greeneville
The Jackson Clinic, PA, Jackson

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Knoxville

RecrutandoFase 3

Idades de 18 a 79 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT07654361

Atomoxetine in Melanocortin Obesity Syndrome

Vanderbilt University Medical Center, Nashville

RecrutandoFase 2

Idades 6 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT06899178

A Study to Improve Skeletal Muscle in Veterans With HIV

Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville

Recrutando

Idades de 20 a 80 · Homens · Atualizado em 26 de jun. de 2026 · NCT06845046

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Holston Medical Group_Bristol, Bristol

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 25 de jun. de 2026 · NCT07607587

Daily Eating Patterns for Total Health Study

Healthy Eating and Activity Laboratory, Knoxville

Recrutando

Idades de 25 a 60 · Todos os sexos · Atualizado em 15 de jun. de 2026 · NCT06455995

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity

MBX Biosciences Investigational Site, Knoxville

RecrutandoFase 1

Idades de 18 a 65 · Todos os sexos · Atualizado em 9 de jun. de 2026 · NCT07142707

EBT Fruit and Vegetable Prescription

Cherokee Health Systems, Dameron Avenue Pedatrics, Knoxville

RecrutandoVoluntários saudáveis bem-vindos

Idades de 4 a 10 · Todos os sexos · Atualizado em 9 de jun. de 2026 · NCT05028205

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

St. Jude Children's Research Hospital, Memphis

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT07228741

Metabolic Effects of Angiotensin-(1-7)

Vanderbilt University Medical Center, Nashville

RecrutandoFase 1

Idades de 18 a 60 · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT02646475

Sympathetic Mechanisms in Obesity-Crossover Design

Vanderbilt University Medical Center, Nashville

RecrutandoFase 1/2

Idades de 18 a 65 · Todos os sexos · Atualizado em 27 de fev. de 2026 · NCT05312892

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

Vanderbilt University Medical Center (Part C only), Nashville

RecrutandoFase 1/2Voluntários saudáveis bem-vindos

Idades de 12 a 65 · Todos os sexos · Atualizado em 22 de dez. de 2025 · NCT06239116

Tirzepatide in PWS, HO and GNSO

Vanderbilt University Medical Center, Nashville

RecrutandoFase 4

Idades de 18 a 26 · Todos os sexos · Atualizado em 16 de set. de 2025 · NCT06901245

Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

University of Tennessee Medical Center, Knoxville

RecrutandoEstudo observacional

Idades de 18 a 45 · Mulheres · Atualizado em 10 de set. de 2025 · NCT06802861

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.